Based on the Stock Research the Relative Strength Index signal is in over sold territory with a range of 26.8.
Patheon N.V. (NYSE:PTHN) has tumbled 11.63% during the past week and has dropped 13.09% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 11.84%. Patheon N.V. (NYSE:PTHN) has underperformed the index by 14.08% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
For the current week, the company shares have a recommendation consensus of Buy. Patheon N.V. (NYSE:PTHN) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.43 points or 1.55% at $27.29 with 1,479,469 shares getting traded. Post opening the session at $27.21, the shares hit an intraday low of $26.84 and an intraday high of $27.53 and the price was in this range throughout the day. The company has a market cap of $3,961 million and the number of outstanding shares has been calculated to be 145,128,650 shares. The 52-week high of Patheon N.V. (NYSE:PTHN) is $32.95 and the 52-week low is $23.7201.
Patheon N.V. is a provider of pharmaceutical development and manufacturing services. Patheon N.V. is based in Amsterdam, Netherlands.